Cite

HARVARD Citation

    Alten, R. et al. (n.d.). P422 Immunogenicity of a proposed adalimumab biosimilar, FKB327, and the reference product in patients with rheumatoid arthritis. Journal of Crohn's and colitis. p. S320. [Online]. 
  
Back to record